2Miwa K,Nakamura J,Hamada Y,et al.The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes[J].Diabetes Res Clin Pract,2003,60(1):1-9.
4Sheetz MJ,King GL.Molecular understanding of hyperglycemia's adverse effects for diabetic complications[J].JAMA,2002,288(20):2 579-2 588.
5Bullock WH,Magnuson SR,Choi S,et al.Prospects for kinase activity modulators in the treatment of diabetes and diabetic complications[J].Curr Top Med Chem,2002,2(9):915-938.
6Xu X,Zhu Q,Xia X,et al.Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats[J].Curr Eye Res,2004,28(4):251-256.
7Yokota T,Ma RC,Park JY,et al.Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes[J].Diabetes,2003,52(3):838-845.
8The PKC-DRS Study Group.The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy:initial results of the protein kinase C beta inhibitor diabetic retinopathy study (PKC-DRS) multicenter randomized clinical trial[J].Diabetes,2005,54(7):2 188-2 197.
9Geraldes P,Hiraoka-Yamamoto J,Matsumoto M,et al.Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy[J].Nat Med,2009,15(11):1 298-1 306.
10Stitt AW.The role of advanced glycation in the pathogenesis of diabetic retinopathy[J].Exp Mol Pathol,2003,75(1):95-108.
